Literature DB >> 1317858

DNA topoisomerase I phosphorylation in murine fibroblasts treated with 12-O-tetradecanoylphorbol-13-acetate and in vitro by protein kinase.

D S Samuels1, N Shimizu.   

Abstract

The phosphorylation of DNA topoisomerase I in quiescent murine 3T3-L1 fibroblasts treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) was characterized by in vivo labeling with [32P] orthophosphate and immunoprecipitation with a scleroderma anti-DNA topoisomerase I autoantibody. DNA topoisomerase I phosphorylation was stimulated 4-fold by 2 h of TPA treatment (TPA at 100 ng/ml maximally enhanced phosphorylation). Purified DNA topoisomerase I was phosphorylated in vitro in a Ca2+ and phospholipid-dependent fashion by types I, II, and III protein kinase C. The phosphorylation reaction was stimulated by TPA and had an apparent K(m) of 0.4 microM. DNA topoisomerase I was phosphorylated in vivo and in vitro predominantly at serine. The major tryptic phosphopeptides from DNA topoisomerase I in TPA-treated fibroblasts and phosphorylated by protein kinase C comigrated in thin-layer electrophoresis. The half-life of incorporated phosphate on DNA topoisomerase I was 40 min in both TPA-treated and control cells. These results suggest that phosphorylation is a mechanism for activating DNA topoisomerase I in fibroblasts treated with TPA and that protein kinase C functions in the phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317858

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Pea DNA topoisomerase I is phosphorylated and stimulated by casein kinase 2 and protein kinase C.

Authors:  Narendra Tuteja; Malireddy Kodandarami Reddy; Yashwanti Mudgil; Badam Singh Yadav; Meena Rani Chandok; Sudhir Kumar Sopory
Journal:  Plant Physiol       Date:  2003-08       Impact factor: 8.340

2.  Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.

Authors:  Keya Bandyopadhyay; Ruth A Gjerset
Journal:  Biochemistry       Date:  2011-01-12       Impact factor: 3.162

3.  Phosphorylation of serine residues in the N-terminal domains of eukaryotic type I topoisomerases.

Authors:  K Staron; D S Samuels
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

4.  PKA controls a level of topoisomerase I mRNA in mouse L5178Y lymphoma cells treated with db-cAMP.

Authors:  R M Czerwinski; K Nieznanski; B Sochanowicz; K Staron
Journal:  Mol Biol Rep       Date:  1994-03       Impact factor: 2.316

5.  Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I.

Authors:  Jennifer S Hackbarth; Marina Galvez-Peralta; Nga T Dai; David A Loegering; Kevin L Peterson; Xue W Meng; Larry M Karnitz; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

6.  Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells.

Authors:  E Cardellini; E Durban
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

7.  The predominant form of mammalian DNA topoisomerase I in vivo has a molecular mass of 100 kDa.

Authors:  D S Samuels; N Shimizu
Journal:  Mol Biol Rep       Date:  1994-03       Impact factor: 2.316

Review 8.  Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Authors:  C J Gerrits; M J de Jonge; J H Schellens; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.